New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 16, 2014
09:14 EDTCLF, CSIQ, VZ, JCP, ADSK, AMAT, WWE, RAX, GME, CHK, BRK.A, JWNOn The Fly: Pre-market Movers
HIGHER: Rackspace (RAX), up 24% after hiring Morgan Stanley after approach by "multiple parties"... Nordstrom (JWN), up 9% following quarterly results and announcing that it will seek a financial partner for its credit card receivables... J.C. Penney (JCP), up 18.5% after reporting better than expected first quarter revenue with same-store sales rising 6.2%... Verizon (VZ), up 1.5% after several noteworthy fund managers, including Warren Buffet's Berkshire Hathaway (BRK.A), disclosed stakes in the telecom company. UP AFTER EARNINGS: Applied Materials (AMAT), up 3.8%... Autodesk (ADSK), up 5%. LOWER: WWE (WWE), down 49% after announcing new television deal, providing guidance, shares being downgraded at Benchmark Co... Chesapeake (CHK), down 3% after announcing it will spin off its Oilfield Services business, lowering its FY14 production, operating cash flow, interest expense and dividend payments outlooks... Cliffs Natural (CLF), down 2.5% after downgraded at Macquarie following the company's reduction in FY14 iron ore price forecasts... Canadian Solar (CSIQ), down 10% after EPS misses forecast... GameStop (GME), down 1.3% after research firm NPD reported data on game and console sales in April.
News For A;AMAT;CSIQ;CHK;ADSK;CLF;GME From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
May 15, 2015
10:45 EDTCHKStocks with call strike movement; CHK RIG
Chesapeake (CHK) October 17 call option implied volatility increased 2% to 45, Transocean (RIG) August 21 call option implied volatility increased 4% to 42 according to IVolatility.
10:40 EDTAMATStocks with call strike movement; MU AMAT
Subscribe for More Information
09:11 EDTAMATOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Bsquare (BSQR), up 34.2%... Applied Materials (AMAT), up 3.2%. ALSO HIGHER: Trillium Therapeutics (TRIL), up 13% after being initiated with an Outperform at Oppenheimer... Pernix Therapeutics (PTX), up 7.4% after announcing FDA approval of Treximet for use in pediatric patients... Advaxis (ADXS), up 4.4% after being initiated with a Buy at Jefferies... Netflix (NFLX), up 3.3% following a Bloomberg report that the company is in talks to enter China's online video market... Inovalon (INOV), up 2.9% after being upgraded to Buy from Neutral at Goldman. DOWN AFTER EARNINGS: El Pollo LoCo (LOCO), down 12.8%... King Digital (KING), down 8.3%. ALSO LOWER: PlasmaTech (PTBI), down 5.4% after filing to sell 1.93M shares for selling stockholders... Paycom Software (PAYC), down 7% after 8M share Spot Secondary priced at $36.25... Keurig Green Mountain (GMCR), down 5.9% after Keurig Kold investor presentation... 3D Systems (DDD), down 2.4% after CFO transition... Celladon (CLDN), down 5.1% after the CEO says that the company is evaluating strategic options.
08:33 EDTAMATApplied Materials reported strong Q2 results, says Pacific Crest
Subscribe for More Information
08:08 EDTADarwin Professional presents positive clinical data for ALD403
Alder BioPharmaceuticals announced that six-month follow-up data from its Phase 2 proof-of-concept clinical trial of ALD403, its anti-calcitonin gene-related peptide, or CGRP, antibody for the prevention of frequent episodic migraine, were presented in an oral presentation at the 17th Congress of the International Headache Society in Valencia, Spain. Key Points from Oral Session: Migraine Pathophysiology and CGRP as a Therapeutic Target: A single intravenous dose of ALD403 1000mg demonstrated prolonged efficacy over six months for the preventive treatment of migraine. Over three months, the proportion of patients with a 50%, 75%, and 100% reduction in migraine days for ALD403 and placebo was 61% vs 33%; 33% vs 9%; and 16% vs 0%, respectively. Over six months, the proportion of patients with a 50%, 75%, and 100% reduction in migraine days for ALD403 and placebo was 53% vs 28%; 26% vs 7%; and 11% vs 0%, respectively. ALD403 was well tolerated and there were no differences from placebo in terms of adverse events or laboratory safety data. The migraine prevention proof-of-concept trial was conducted in 163 patients with frequent episodic migraine who had on average nine headache days per month. Patients were given a single intravenous dose of 1000mg of ALD403 or placebo. The primary endpoint was the mean change in migraine headache days from baseline to weeks 5-8, and patients were followed for 24 weeks for additional safety and efficacy analyses.
06:30 EDTAMATApplied Materials outlook positive, downside limited, says Piper Jaffray
Subscribe for More Information
05:52 EDTGMEApril NPD video game software sales rose 13%, says Piper Jaffray
Piper Jaffray notes April NPD video game software sales increased 13% year-over-year with next-generation software revenue up 200% versus the prior year. Piper keeps Overweight ratings on Activision Blizzard (ATVI), Electronic Arts (EA), GameStop (GME) and Take-Two (TTWO).
May 14, 2015
19:02 EDTAMATOn The Fly: After Hours Movers
Subscribe for More Information
16:05 EDTAMATApplied Materials sees Q3 EPS 31c-35c, consensus 33c
Subscribe for More Information
16:03 EDTAMATApplied Materials reports Q2 EPS 29c, consensus 28c
Subscribe for More Information
15:01 EDTAMATNotable companies reporting after market close
Subscribe for More Information
14:34 EDTAMATApplied Materials technical remarks before results
The stock's chart over the last year has been marked by two large double tops that completed, and from which new rallies began in the case of the former in October of last year. Ahead of earnings, the current double top has largely completed. If the news and outlook is more bullish than expected, then a new rally may begin from current levels. Resistance levels to watch as potential upside objectives would be at $20,60, $21.44, $22.69, and $23.46. If the news is bearish, given the preceding double top the downside could be significant. Support levels to watch as potential downside objectives are at $18.63, $17.69, and $16.40.
13:28 EDTCHKIncreasing equity options volume
Increasing equity options volume: FCX UPS KSS CHK CSCO AVP YOKU CALM KORS
11:43 EDTAMATApplied Materials May volatility elevated into Q3 and outlook
Applied Materials May call option implied volatility is at 72, June is at 29, July is at 28; compared to its 90-day average of 29; suggesting large near term price movement into the expected release of Q3 results today after the market close.
09:03 EDTADSKAutodesk weakness a buying opportunity, says Baird
Subscribe for More Information
07:59 EDTADSKAutodesk June volatility elevated into Q1 and outlook
Subscribe for More Information
May 13, 2015
11:28 EDTCHKStocks with call strike movement; TWTR JCP
Subscribe for More Information
08:08 EDTAAgilent volatility elevated into Q1 and sales outlook
Subscribe for More Information
May 12, 2015
08:04 EDTCHKCitigroup to hold a conference
Subscribe for More Information
05:59 EDTAMATPiper sees opportunity in Applied Materials ahead of earnings
Piper Jaffray views the recent pullback in shares of Applied Materials as an opportunity ahead of the company's earnings this week. Piper sees limited downside from current levels and believes the Applied's WFE outlook "will not deviate much from that of its peers." The firm reiterates an Overweight rating on the stock with a $25 price target.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use